Lopez, Ricky .

HRN: 23-23-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2023
CEFTRIAXONE 1G (VIAL)
06/28/2023
07/05/2023
IV DRIP
470mg
Q24
PCAP-D
Waiting Final Action 
06/28/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/28/2023
07/05/2023
IV
350mg
Q6
PCAP D
Waiting Final Action 
07/02/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/02/2023
07/08/2023
IVT
70 Mg
Q24
PCAP D
Waiting Final Action 
07/10/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
07/10/2023
07/17/2023
PO
1.4ml
BID
PCAP-D
Waiting Final Action 
07/12/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/12/2023
07/15/2023
IV
70mg
OD
PCAP-D
Waiting Final Action 
07/12/2023
CEFTAZIDIME 1GM (VIAL)
07/12/2023
07/19/2023
IV
155mg
Q8hours
PCAP-D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: